Harold E Huber

Title: Harold E Huber: Innovator in Pharmaceutical Compositions

Introduction

Harold E Huber is a notable inventor based in Cincinnati, OH (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 3 patents, showcasing his innovative approach to addressing women's health issues.

Latest Patents

One of Huber's latest patents involves pharmaceutical compositions of conjugated estrogens and methods for their preparation. This invention focuses on novel pharmaceutical compositions designed for the treatment of peri-menopausal, menopausal, and post-menopausal disorders in women. The compositions consist of a carrier base material and conjugated estrogens formed into a solid unit dosage form, which provides a regular incremental release of the medicament upon oral administration. Additionally, the invention includes the combination of conjugated estrogens with progestogens in a solid, shaped dosage unit. Specifically, it describes the use of organic excipients such as high molecular weight hydroxyalkyl alkylcelluloses and hydroxypropylmethylcellulose in stable, solid dosage formulations.

Another significant patent by Huber is a coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine composition, which is suitable for pharmaceutical use. These innovations reflect Huber's commitment to improving therapeutic options for women.

Career Highlights

Throughout his career, Harold E Huber has worked with prominent companies in the pharmaceutical industry, including Richardson-Merrell Inc. and Duramed Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical solutions.

Collaborations

Huber has collaborated with various professionals in the field, including his coworker Mary Katherine Ryan. These partnerships have likely enhanced his research and development efforts.

Conclusion

Harold E Huber's contributions to pharmaceutical innovations, particularly in women's health, demonstrate his significant impact on the industry. His patents reflect a dedication to advancing medical treatments and improving patient care.